Tech Company Financing Transactions
Verax Biomedical Funding Round
On 3/2/2016, Verax Biomedical landed $12.6 million in financing from private investors.
Transaction Overview
Company Name
Announced On
3/2/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$12,554,365
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 56 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
148 Bartlett St.
Marlborough, MA 01752
USA
Marlborough, MA 01752
USA
Phone
Website
Email Address
Overview
Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Lousararian
VP - Bus. Development
Joe Sanders
VP - Finance
Paul Ragusa
VP - Operations
Scott McKenzie
VP - R & D
Yli Vallejo
VP - Regulatory Affairs
Nancy Hornbaker
Browse more venture capital transactions:
Prev: 3/2/2016: WellDoc venture capital transaction
Next: 3/2/2016: TripActions venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs